AVAH Form 4 reports acquisition/exercise transactions

Shaner Jeff reported acquisition or exercise transactions in a Form 4 filing for AVAH.

Accepted by SEC EDGAR 02/17/2026 - 05:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Shaner Jeff reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 715,229 shares. Following the reported transactions, holdings were 3,112,801 shares.

Insider Trade Summary

Grant/Award: 715,229 shares

Grant/Award 3 txns

Insider Shaner Jeff

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	136,663	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	421,094	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	157,472	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 3,112,801 shares (Direct)

Footnotes (4)

1. F1. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2022 long-term incentive awards.
2. F2. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2023 long-term incentive awards.
3. F3. Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.
4. F4. Includes 3,393 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in December 2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Aveanna (AVAH) CEO Jeff Shaner report?

Jeff Shaner reported three stock award transactions. He acquired 136,663 shares and 421,094 shares from vesting of 2022 and 2023 performance-based restricted stock units, and received a new grant of 157,472 stock-settled restricted stock units, all reported at a price of $0 per share.

How many Aveanna (AVAH) shares does CEO Jeff Shaner own after these awards?

Jeff Shaner beneficially owns 3,112,801 Aveanna shares after the awards. This total reflects all reported common stock holdings, including 3,393 shares previously acquired through the company’s Employee Stock Purchase Plan in December 2025 and the newly vested and granted stock-based awards.

What are the 2022 performance-based RSU awards reported by Aveanna (AVAH) CEO?

The 2022 performance-based RSUs vested into 136,663 shares. These shares were earned upon vesting of performance-based restricted stock units issued under the company’s 2022 long-term incentive awards, and were reported as acquired at a transaction price of $0 per share on February 14, 2026.

What 2023 performance-based RSUs did Aveanna (AVAH) CEO Jeff Shaner receive?

The 2023 performance-based RSUs produced 421,094 shares. These shares were earned when performance-based restricted stock units granted under the company’s 2023 long-term incentive awards vested, with the Form 4 showing the acquisition at a per-share transaction price of $0 on February 14, 2026.

What is the three-year cliff-vesting RSU grant reported by Aveanna (AVAH) CEO?

Jeff Shaner received 157,472 stock-settled restricted stock units. This grant is subject to three-year cliff vesting, meaning the units vest in full after three years, rather than gradually, and will settle in shares of Aveanna common stock if vesting conditions are satisfied.

How does the Employee Stock Purchase Plan affect Aveanna (AVAH) CEO’s holdings?

The CEO’s holdings include shares from the Employee Stock Purchase Plan. His total of 3,112,801 shares incorporates 3,393 shares acquired through the company’s Employee Stock Purchase Plan in December 2025, in addition to the vested performance-based RSUs and the newly granted restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shaner Jeff

(Last) (First) (Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/14/2026		A		136,663(1)	A	$0	2,534,235(4)	D
Common Stock, par value $0.01 per share	02/14/2026		A		421,094(2)	A	$0	2,955,329	D
Common Stock, par value $0.01 per share	02/14/2026		A		157,472(3)	A	$0	3,112,801	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2022 long-term incentive awards.

2. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2023 long-term incentive awards.

3. Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

4. Includes 3,393 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in December 2025

	/s/ Jonathan Beckler, Attorney-in-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.